• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Exacerbation of combined pulmonary fibrosis and emphysema syndrome during tocilizumab therapy for rheumatoid arthritis.

作者信息

Wendling Daniel, Vidon Claire, Godfrin-Valnet Marie, Rival Gilles, Guillot Xavier, Prati Clément

机构信息

Service de rhumatologie, CHRU de Besançon, boulevard Fleming, 25030 Besançon, France.

出版信息

Joint Bone Spine. 2013 Dec;80(6):670-1. doi: 10.1016/j.jbspin.2013.03.009. Epub 2013 Apr 23.

DOI:10.1016/j.jbspin.2013.03.009
PMID:23618802
Abstract
摘要

相似文献

1
Exacerbation of combined pulmonary fibrosis and emphysema syndrome during tocilizumab therapy for rheumatoid arthritis.类风湿关节炎患者接受托珠单抗治疗期间合并肺纤维化和肺气肿综合征病情加重
Joint Bone Spine. 2013 Dec;80(6):670-1. doi: 10.1016/j.jbspin.2013.03.009. Epub 2013 Apr 23.
2
A fatal case of acute exacerbation of interstitial lung disease in a patient with rheumatoid arthritis during treatment with tocilizumab.一例类风湿关节炎患者在接受托珠单抗治疗期间发生间质性肺病急性加重导致的致命病例。
Rheumatol Int. 2012 Dec;32(12):4023-6. doi: 10.1007/s00296-010-1525-z. Epub 2010 May 18.
3
Tocilizumab-induced pulmonary fibrosis in a patient with rheumatoid arthritis.托珠单抗诱发的类风湿关节炎患者肺纤维化
Clin Med (Lond). 2020 Mar;20(Suppl 2):s57. doi: 10.7861/clinmed.20-2-s57.
4
[Rheumatoid arthritis and combined pulmonary fibrosis and emphysema].类风湿关节炎合并肺纤维化和肺气肿
Medicina (B Aires). 2015;75(4):225-8.
5
Association of disease activity with acute exacerbation of interstitial lung disease during tocilizumab treatment in patients with rheumatoid arthritis: a retrospective, case-control study.类风湿关节炎患者使用托珠单抗治疗期间疾病活动与间质性肺疾病急性加重的相关性：一项回顾性病例对照研究。
Rheumatol Int. 2016 Jun;36(6):881-9. doi: 10.1007/s00296-016-3478-3. Epub 2016 Apr 12.
6
Fatal fibrosing alveolitis with certolizumab.使用赛妥珠单抗导致的致命性肺纤维化
Rheumatology (Oxford). 2012 May;51(5):953-5. doi: 10.1093/rheumatology/ker452. Epub 2012 Feb 10.
7
Pulmonary fibrosis in a patient with rheumatoid arthritis treated with adalimumab.使用阿达木单抗治疗的类风湿关节炎患者出现的肺纤维化。
Arthritis Rheum. 2006 Feb 15;55(1):157-9. doi: 10.1002/art.21716.
8
[Interstitial lung disease in rheumatoid arthritis].[类风湿关节炎中的间质性肺疾病]
Nihon Rinsho. 1990 Mar;48(3):525-9.
9
[Fibrosing alveolitis after treatement of rheumatoid arthritis by infliximab].英夫利昔单抗治疗类风湿关节炎后出现的纤维化肺泡炎
Presse Med. 2009 Oct;38(10):e17-20. doi: 10.1016/j.lpm.2008.12.031. Epub 2009 May 17.
10
Adalimumab-associated pulmonary fibrosis reply.阿达木单抗相关的肺纤维化回应。
Rheumatology (Oxford). 2007 Aug;46(8):1379-80; author reply 1379. doi: 10.1093/rheumatology/kem038. Epub 2007 Jun 6.

引用本文的文献

1
The Molecular Blueprint for Chronic Obstructive Pulmonary Disease (COPD): A New Paradigm for Diagnosis and Therapeutics.慢性阻塞性肺疾病（COPD）的分子蓝图：诊断和治疗的新模式。
Oxid Med Cell Longev. 2023 Dec 21;2023:2297559. doi: 10.1155/2023/2297559. eCollection 2023.
2
A retrospective study of the efficacy of JAK inhibitors or abatacept on rheumatoid arthritis-interstitial lung disease.JAK 抑制剂或阿巴西普治疗类风湿关节炎-间质性肺病的疗效回顾性研究。
Inflammopharmacology. 2022 Jun;30(3):705-712. doi: 10.1007/s10787-022-00936-w. Epub 2022 Apr 24.
3
Interstitial lung disease occurring shortly after tocilizumab infusion in a patient with polyarticular juvenile idiopathic arthritis: a case report.
一名多关节型幼年特发性关节炎患者在使用托珠单抗输注后不久发生间质性肺病：病例报告
Allergy Asthma Clin Immunol. 2021 Sep 8;17(1):90. doi: 10.1186/s13223-021-00594-7.
4
Adverse effects of biologic anti-inflammatory agents on the respiratory system: A review.生物抗炎药对呼吸系统的不良反应：综述
Afr J Thorac Crit Care Med. 2021 Jun 23;27(2). doi: 10.7196/AJTCCM.2021.v27i2.117. eCollection 2021.
5
Predictors of Progression and Mortality in Patients with Prevalent Rheumatoid Arthritis and Interstitial Lung Disease: A Prospective Cohort Study.类风湿关节炎合并间质性肺疾病患者病情进展及死亡率的预测因素：一项前瞻性队列研究
J Clin Med. 2021 Feb 20;10(4):874. doi: 10.3390/jcm10040874.
6
Progress in the mechanism and targeted drug therapy for COPD.COPD 的发病机制及靶向药物治疗的研究进展。
Signal Transduct Target Ther. 2020 Oct 27;5(1):248. doi: 10.1038/s41392-020-00345-x.
7
Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows.类风湿关节炎相关间质性肺疾病的治疗：光明与阴影
J Clin Med. 2020 Apr 10;9(4):1082. doi: 10.3390/jcm9041082.
8
Current and Emerging Drug Therapies for Connective Tissue Disease-Interstitial Lung Disease (CTD-ILD).当前和新兴的结缔组织病-间质性肺病（CTD-ILD）药物治疗。
Drugs. 2019 Sep;79(14):1511-1528. doi: 10.1007/s40265-019-01178-x.
9
Biologic Treatments in Interstitial Lung Diseases.间质性肺疾病的生物治疗
Front Med (Lausanne). 2019 Mar 13;6:41. doi: 10.3389/fmed.2019.00041. eCollection 2019.
10
IL-17AGM-CSF Neutrophils Are the Major Infiltrating Cells in Interstitial Lung Disease in an Autoimmune Arthritis Model.在自身免疫性关节炎模型中，白细胞介素-17A/粒细胞-巨噬细胞集落刺激因子中性粒细胞是间质性肺病中的主要浸润细胞。
Front Immunol. 2018 Jul 2;9:1544. doi: 10.3389/fimmu.2018.01544. eCollection 2018.